An Oncology focused consulting firm
Drug development is a high-risk, complex, and resource-intensive endeavor. While your time is critical in navigating asset/s through clinical stages, Oncofocus could be your extended intelligence team in identifying potential competitors, tracking their moves, and analyzing implications of the pivotal events.
We have years of experience in supporting our clients through strategic projects like asset prioritization, licensing opportunities evaluation, targeted product profile...
Preclinical to Commercialization:
Research support across all stages of drug development
BCMA CAR-T Pipeline Landscape
B-cell Maturation Antigen (BCMA) is an antigen that has been shown to be specifically expressed in the myeloma cells. We performed a comprehensive pipeline analysis of BCMA targeting CAR-Ts in the Multiple Myeloma indication.
Resources
A repository of our publicly available research work analyzing novel trends in the Oncology landscape
BCMA CAR-T Pipeline Landscape
NOV 2019
#sclc #immunotherapy
BCMA CAR-T Pipeline Landscape
NOV 2019
#oncology #cart #celltherapy
Testimonials
Project Director,
A mid-size Pharma company
A very professional clear and concise final report on the assessment of the most appropriate cancer for further investigation of our asset.
A substantial body of literature evidence was generated to support the final selections. A job very thorughly and comprehensively conducted.
Chief Medical Officer,
A fast-growing biotech firm
This is fantastic and as I assumed ! Thank you Ashish. I am so happy for this collaboration.
CEO and MD,
A new-age Pharma company
Team is quite flexible for changes in processes and approaches and ensure that they adopt the changes to meet the expectation in terms of quality as well as timelines. Many thanks to the team for their endless support.
Solutions
Our extensive experience in the Oncology domain, along with our framework-driven analytical approach, enables us to provide actionable insights
Strategic Insights
We leverage our domain expertise, years of experience, and deep research capability to build strategic solutions that inform your decision-making process and enable you to achieve your strategic objectives quickly.
Asset / Indication Prioritization
Early Asset Evaluation
Licensing Opportunities Evaluation
Competitive Intelligence
"...If you only know yourself, but not your opponent, you may win or may lose..." - Sun Tzu from Art of War. We help you identify your opponents, diligently track them, and understand emerging competitive threats.
Competitive Environment Analysis
Competitor Profiling & Threat Assessment
Product / Portfolio Benchmarking
Conference Intelligence
Conferences are ‘THE’ intelligence events when it comes to competitor's clinical/commercial positioning strategy. Our extensive experience in conference intelligence enables you to stay a step ahead of the rest.
Competitive Landscape Evolution
Competitor Brand Positioning Strategy
Physicians' Evolving Perceptions
Specialty Services
Trial registries and publication aggregators are not just repositories. They also ‘speak’ about competitor positioning, emerging research strategies, and opinion leaders. Oncofocus helps you in ‘listening’ to these cues.
KOL Identification & Profiling
Competitor Scientific Positioning
Novel/Emerging Research Strategies
Primary Market Research
We cater to the primary market research needs of the healthcare domain through decodeMR, our in-house team, which is well-reputed for its strength in the qualitative research arena.
Market Potential Assessment
Brand Perception Studies
Pricing Sensitivity Research
Products
Regular tracking of >4,000 oncology assets across multiple parameters enable us to quickly develop strategic solutions that can be relied on for decision-making process
Cell & Gene Therapy Watch
A repository dedicated to track 3,000+ Cell and Gene Therapy asset's in-depth details from types of cells, structural components, manufacturing techniques to outcomes reported on each asset.
Immunotherapy Watch
Our optimally-designed 'Immunotherapy Watch' with 700+ assets keeps us abreast of the rapidly evolving Immuno-Oncology field and allows us to do a comprehensive analysis in a short time.